Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
ASNI Calgary 2015
Neuroscience: Improving Translation of Animal Models for Nervous System Disorders: A Workshop
[Th17-mediated relapsing-remitting multiple sclerosis is nonresponsive to interferon-β1b].
Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions.
Acute disseminated encephalomyelitis in 228 patients: A retrospective, multicenter US study.
Individual Neuronal Subtypes Exhibit Diversity in CNS Myelination Mediated by Synaptic Vesicle Release.
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis.
The mediating role of processing speed in the relationship between depressive symptoms and cognitive function in multiple sclerosis.
CCL genes in multiple sclerosis and systemic lupus erythematosus.
Interrater Reliability of Four Sensory Measures in People with Multiple Sclerosis.
[Flow cytometry model for the detection of neutralizing antibodies against of IFN-β].
Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine.
Impact of Disease-Modifying Therapies on the Survival of Patients with Multiple Sclerosis in Taiwan, 1997-2008.
Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis
Activity-Dependent and Experience-Driven Myelination Provide New Directions for the Management of Multiple Sclerosis.
Immune Tolerance and Autoimmune Disease Conference
Episode 33 with Dr. Pierre-Antoine Gourraud on the role of human leukocyte antigen in MS
Prevalence of Multiple Sclerosis in the Republic of Moldova.
Brain and BrainPET 2015
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation.
The effectiveness of dimethyl fumarate monotherapy in the treatment of relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
Alemtuzumab-Related Thyroid Dysfunction in a Phase 2 Trial of Patients with Relapsing-Remitting Multiple Sclerosis.
Epigenetics of Multiple Sclerosis: An Updated Review.
Effect of smoking on multiple sclerosis: a meta-analysis.
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study.
Pages
« first
‹ previous
…
63
64
65
66
67
68
69
70
71
…
next ›
last »